3-{[(4-chlorophenyl)methyl]sulfanyl}-4-ethyl-5-(2-phenyl-1,3-thiazol-4-yl)-4H-1,2,4-triazole

Catalog No. :
ACYKVV935
CAS No. :
338759-67-4
Molecular Formula :
C20H17ClN4S2
Molecular Weight :
412.97

IUPAC Name:4-(5-((4-chlorobenzyl)thio)-4-ethyl-4H-1,2,4-triazol-3-yl)-2-phenylthiazole

3-{[(4-chlorophenyl)methyl]sulfanyl}-4-ethyl-5-(2-phenyl-1,3-thiazol-4-yl)-4H-1,2,4-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[(4-chlorophenyl)methyl]sulfanyl}-4-ethyl-5-(2-phenyl-1,3-thiazol-4-yl)-4H-1,2,4-triazole
IUPAC Name4-(5-((4-chlorobenzyl)thio)-4-ethyl-4H-1,2,4-triazol-3-yl)-2-phenylthiazole
MDL No.MFCD00171873
Molecular FormulaC20H17ClN4S2
Molecular Weight412.97
SMILESCCN1C(SCC2=CC=C(Cl)C=C2)=NN=C1C3=CSC(C4=CC=CC=C4)=N3
InChI KeyRMSFAIMJYRDDTA-UHFFFAOYSA-N
Synonym4-CHLOROBENZYL 4-ETHYL-5-(2-PHENYL-1,3-THIAZOL-4-YL)-4H-1,2,4-TRIAZOL-3-YL SULFIDE;3-[(4-CHLOROBENZYL)SULFANYL]-4-ETHYL-5-(2-PHENYL-1,3-THIAZOL-4-YL)-4H-1,2,4-TRIAZOLE;3-{[(4-chlorophenyl)methyl]sulfanyl}-4-ethyl-5-(2-phenyl-1,3-thiazol-4-yl)-4H-1,2,4-triazole;4H-1,2,4-Triazole, 3-[[(4-chlorophenyl)methyl]thio]-4-ethyl-5-(2-phenyl-4-thiazolyl)-
CAS No.338759-67-4

Synthetic Route by SureRoute

1. ACYKVV935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYKVV935 route product structure diagram
    ACYKVV935338759-67-4
Inquiry

2. ACYKVV935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYKVV935 route product structure diagram
    ACYKVV935338759-67-4
Inquiry

Comments (0)